These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 34588308)
1. DNA origami patterning of synthetic T cell receptors reveals spatial control of the sensitivity and kinetics of signal activation. Dong R; Aksel T; Chan W; Germain RN; Vale RD; Douglas SM Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34588308 [TBL] [Abstract][Full Text] [Related]
2. Tight nanoscale clustering of Fcγ receptors using DNA origami promotes phagocytosis. Kern N; Dong R; Douglas SM; Vale RD; Morrissey MA Elife; 2021 Jun; 10():. PubMed ID: 34080973 [TBL] [Abstract][Full Text] [Related]
13. Chimeric Antigen Receptor-Modified T Cells and T Cell-Engaging Bispecific Antibodies: Different Tools for the Same Job. Schwerdtfeger M; Benmebarek MR; Endres S; Subklewe M; Desiderio V; Kobold S Curr Hematol Malig Rep; 2021 Apr; 16(2):218-233. PubMed ID: 33939108 [TBL] [Abstract][Full Text] [Related]
14. The Intracellular Domain of CD40 is a Potent Costimulatory Element in Chimeric Antigen Receptors. Levin-Piaeda O; Levin N; Pozner S; Danieli A; Weinstein-Marom H; Gross G J Immunother; 2021 Jul-Aug 01; 44(6):209-213. PubMed ID: 34010245 [TBL] [Abstract][Full Text] [Related]
16. Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy. Ghassemi S; Milone MC J Vis Exp; 2019 Dec; (154):. PubMed ID: 31904011 [TBL] [Abstract][Full Text] [Related]
17. Signaling from T cell receptors (TCRs) and chimeric antigen receptors (CARs) on T cells. Wu L; Wei Q; Brzostek J; Gascoigne NRJ Cell Mol Immunol; 2020 Jun; 17(6):600-612. PubMed ID: 32451454 [TBL] [Abstract][Full Text] [Related]
18. Generation of Chimeric Antigen Receptor T Cells Using Gammaretroviral Vectors. Mo F; Mamonkin M Methods Mol Biol; 2020; 2086():119-130. PubMed ID: 31707671 [TBL] [Abstract][Full Text] [Related]
19. Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells. Grunewald CM; Haist C; König C; Petzsch P; Bister A; Nößner E; Wiek C; Scheckenbach K; Köhrer K; Niegisch G; Hanenberg H; Hoffmann MJ Front Immunol; 2021; 12():782448. PubMed ID: 34868059 [TBL] [Abstract][Full Text] [Related]
20. Engineering genetic devices for in vivo control of therapeutic T cell activity triggered by the dietary molecule resveratrol. Yang L; Yin J; Wu J; Qiao L; Zhao EM; Cai F; Ye H Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34404729 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]